FDA Approved: FYLNETRA — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves FYLNETRA (pegfilgrastim) from Amneal as an original biologics license application to help reduce the duration of neutropenia in adults receiving my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Neutropenia
• Nonmyeloid Malignancies

Drugs mentioned

• FYLNETRA (PEGFILGRASTIM)

Snippet

ORIG AP for FYLNETRA (PEGFILGRASTIM)